Impact of the COVID-19 pandemic on colorectal cancer screening in New York City.

IF 2.6 4区医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Journal of Medical Screening Pub Date : 2023-06-01 DOI:10.1177/09691413221128666

Briton Lee, Sigrid Young, Renee Williams, Peter S Liang

{"title":"Impact of the COVID-19 pandemic on colorectal cancer screening in New York City.","authors":"Briton Lee, Sigrid Young, Renee Williams, Peter S Liang","doi":"10.1177/09691413221128666","DOIUrl":null,"url":null,"abstract":"Background: The COVID-19 pandemic significantly impacted the delivery of cancer screening. The resulting decrease in outpatient visits and cancellations of non-urgent procedures have negatively affected colorectal cancer (CRC) screening. We aimed to determine the effect of the pandemic on CRC screening at a safety-net hospital and a private health system based in New York City.Methods: We identified individuals eligible for CRC screening aged 50 to 75 years presenting for outpatient care at a safety-net public hospital and private health system in April through September of 2019 and 2020. The primary outcome was the proportion of screening-eligible patients seen in primary care who underwent CRC screening.Results: The safety-net hospital had 516 (6.1% of screening-eligible individuals) and 269 (4.3%) screening tests completed in 2019 and 2020, respectively (p < 0.01). Fecal immunochemical tests (FIT) accounted for 69.6% of screening in 2019 and 88.1% in 2020. Colonoscopy accounted for 20.3% of screening in 2019 and 11.9% in 2020. The private health system had 39 (0.7%) and 21 (0.6%) screening tests completed in 2019 and 2020, respectively (p = 0.48). FIT accounted for 61.9% of screening in 2019 and 57.1% in 2020. Colonoscopy accounted for 38.1% of screening in 2019 and 42.9% in 2020.Conclusion: Absolute numbers of screening tests decreased for both institutions during the COVID-19 pandemic. We observed a decrease in screening uptake and increase in proportional FIT use in the safety-net hospital but no change in the private health system.","PeriodicalId":51089,"journal":{"name":"Journal of Medical Screening","volume":"30 2","pages":"81-86"},"PeriodicalIF":2.6000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513512/pdf/10.1177_09691413221128666.pdf","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Screening","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/09691413221128666","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 4

Abstract

Background: The COVID-19 pandemic significantly impacted the delivery of cancer screening. The resulting decrease in outpatient visits and cancellations of non-urgent procedures have negatively affected colorectal cancer (CRC) screening. We aimed to determine the effect of the pandemic on CRC screening at a safety-net hospital and a private health system based in New York City.

Methods: We identified individuals eligible for CRC screening aged 50 to 75 years presenting for outpatient care at a safety-net public hospital and private health system in April through September of 2019 and 2020. The primary outcome was the proportion of screening-eligible patients seen in primary care who underwent CRC screening.

Results: The safety-net hospital had 516 (6.1% of screening-eligible individuals) and 269 (4.3%) screening tests completed in 2019 and 2020, respectively (p < 0.01). Fecal immunochemical tests (FIT) accounted for 69.6% of screening in 2019 and 88.1% in 2020. Colonoscopy accounted for 20.3% of screening in 2019 and 11.9% in 2020. The private health system had 39 (0.7%) and 21 (0.6%) screening tests completed in 2019 and 2020, respectively (p = 0.48). FIT accounted for 61.9% of screening in 2019 and 57.1% in 2020. Colonoscopy accounted for 38.1% of screening in 2019 and 42.9% in 2020.

Conclusion: Absolute numbers of screening tests decreased for both institutions during the COVID-19 pandemic. We observed a decrease in screening uptake and increase in proportional FIT use in the safety-net hospital but no change in the private health system.

查看原文本刊更多论文

COVID-19大流行对纽约市结直肠癌筛查的影响

背景:COVID-19大流行显著影响了癌症筛查的提供。由此导致的门诊就诊减少和非紧急手术的取消对结直肠癌(CRC)筛查产生了负面影响。我们的目的是确定大流行对纽约市一家安全网医院和一家私人卫生系统的CRC筛查的影响。方法:我们确定了2019年4月至9月和2020年4月至9月在安全网公立医院和私立卫生系统门诊就诊的年龄在50至75岁之间符合CRC筛查条件的个体。主要结局是在初级保健中接受CRC筛查的符合筛查条件的患者的比例。结果:安全网医院2019年和2020年分别完成筛查516例(占筛查合格者的6.1%)和269例(占筛查合格者的4.3%)(p < 0.01)。2019年，粪便免疫化学测试(FIT)占筛查的69.6%，2020年为88.1%。结肠镜检查占2019年筛查的20.3%，2020年为11.9%。私立卫生系统在2019年和2020年分别完成了39项(0.7%)和21项(0.6%)筛查测试(p = 0.48)。FIT占2019年筛查的61.9%，2020年为57.1%。结肠镜检查占2019年筛查的38.1%，2020年为42.9%。结论:在COVID-19大流行期间，这两个机构的筛查检测绝对数量都有所下降。我们观察到，在安全网医院中，筛查率下降，比例FIT使用增加，但在私立卫生系统中没有变化。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Medical Screening 医学-公共卫生、环境卫生与职业卫生

CiteScore

4.90

自引率

3.40%

发文量

审稿时长

>12 weeks

期刊介绍： Journal of Medical Screening, a fully peer reviewed journal, is concerned with all aspects of medical screening, particularly the publication of research that advances screening theory and practice. The journal aims to increase awareness of the principles of screening (quantitative and statistical aspects), screening techniques and procedures and methodologies from all specialties. An essential subscription for physicians, clinicians and academics with an interest in screening, epidemiology and public health.